UNSPSC 51172826: Glycerin/kaolin/sodium fluoride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OR900. This VA Drug Class (OR900) classifies this compound as belonging to the group DENTAL AND ORAL AGENTS, TOPICAL, OTHER.

UNSPSC 51172826 Glycerin/kaolin/sodium fluoride is a Commodity code covering active pharmaceutical ingredients and over-the-counter topical and oral products, as demonstrated by state and local procurement of these items through cooperative purchasing agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, solicited manufacturers of generic multi-source pharmaceuticals and OTC products in January 2026 to supply state and local government facilities across participating jurisdictions including Oregon. State and local entities use this code to procure finished pharmaceutical and OTC products—such as toothpastes, gels, and oral rinses containing glycerin, kaolin, and sodium fluoride—through cooperative purchasing vehicles that aggregate demand across multiple agencies and states, reducing per-unit costs through volume commitments and standardized contracting.

The MMCAP RFP issued January 20, 2026, with proposals due March 26, 2026, seeks manufacturers to provide comprehensive pricing and product data for identified National Drug Codes (NDCs), with awarded contracts effective July 1, 2026, and running two years for new responders. Vendors must maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, Morris & Dickson Co., LLC), certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, carry professional liability and commercial general liability insurance of $2,000,000 and $5,000,000 per occurrence respectively, and accept pricing flexibility including flat pricing, net price formats (NF30, NF60, NF90), or WAC-minus structures. The evaluation weights price competitiveness at 75 percent, with the remaining 25 percent allocated to fixed pricing (10 percent), EDI capability (5 percent), administrative format compliance (5 percent), and agreement to a 3 percent administrative fee (5 percent). No specific set-aside or disadvantaged-enterprise restrictions were disclosed in available documentation. Questions were due February 18, 2026.